• Español
  • English
  • facebook
  • twitter
  • rss
  • Español
  • English
  • facebook
  • twitter
  • rss
TNI D&D
  • Home
  • About us
    • About us
    • People
    • Partners
    • Researchers
    • Contact us
    • In the media
    • Newsletter
  • Newsroom
    • Press contacts
    • Press releases
    • Resources
    • Drugs in the news
  • Issues
    • Drug policy debate in the Americas
    • Decriminalization
    • Proportionality of sentences
    • Harm reduction
    • Reclassification of substances
    • Safer crack use
    • Human rights
    • Regulation
    • Unscheduling the coca leaf
    • Ending the war on drugs
    • Alternative development
    • Cannabis
    • Producers of Crops
    • Law enforcement
    • ATS, Mild stimulants & NPS
    • European Drug Policy
    • Money Laundering
  • UN Drug
    Control
    • Conventions
    • UNODC
    • CND
    • INCB
    • UNGASS
  • Country
    information
    • Drug Law Reform on the Map
    • Central America
      • El Salvador
      • Guatemala
      • Honduras
      • Costa Rica
    • Latin America
      • Argentina
      • Bolivia
      • Paraguay
      • Brazil
      • Chile
      • Colombia
      • Ecuador
      • Peru
      • Uruguay
      • Venezuela
    • Mexico
    • Caribbean
      • Jamaica
      • Belize
    • Afghanistan
  • Events
    • Expert Seminars
    • Informal Policy Dialogues
    • Public Events
    • Judges for Law Reform
  • Publications
    • Drug Policy Briefings
    • Drug Law Reform
    • Legislative Reform Series
    • The Human Face
    • Drugs & conflict
    • Drugs and the Law (CEDD)
      • Systems overload
    • Drug Markets and Violence
  • Weblog

 

The INCB on Harm Reduction

Catching Up, or Holding Back?

As in years past, the International Narcotics Control Board (INCB) highlights the problem of HIV epidemics fuelled by injection drug use in its 2007 annual report. The phrase harm reduction is used in the report without scare quotes but the Board cannot refrain from sounding cautionary notes.

The 2007 report mentions HIV 54 times. On harm reduction measures to reduce such HIV infections, the 2007 report demonstrates some small positive changes. In contrast to the report on 2006 and 2005, where provision of sterile syringes went unmentioned, the Board notes provision of sterile syringes in its review of developments in countries including Viet Nam, Malaysia, and Australia, as well as 24 European Union member States (paras 510, 511, 706, 653 inter alia).

The Board cannot refrain from sounding cautionary notes - the INCB calls on Australia to ensure that sterile syringe programs in New South Wales, for example (para 706), are carried out in compliance with the provisions of the international drug control conventions, despite previous declarations from the Board and legal experts that such programs do not violate any convention. When calling for adequate services for drug offenders in prison (para 26), the Board does not mention needle exchange, despite clear guidance by WHO and other authorities about the benefits of such services in penal institutions. Instead, the Board calls on governments to ensure that access to illicit drugs in prisons is terminated (para 60 (d)). Nonetheless, compared with the silence in previous years, these mentions of needle exchange are important.

The phrase harm reduction is used in the report on 2007 without scare quotes. This should be unremarkable given the endorsement of increased availability of harm reduction by all member States in the 2001 Declaration of Commitment on HIV/AIDS and multiple other United Nations documents such as the 2008 United Nations Office on Drugs and Crime discussion paper (endorsed by the INCB) on reducing the adverse health and social consequences of drug use. However, it is a notable departure for the INCB.

The Board also matter-of-factly notes the implementation of addiction treatment with methadone or buprenorphine in countries including the United States, the Islamic Republic of Iran, Canada, Viet Nam, Malaysia, and all European Union member States (paras 99, 510, 511, 653 inter alia).

Those hoping that the Board would more actively pursue its mandate to ensure adequate availability of licit drugs for medical purposes, however, will find little cause for optimism in the report on 2007. As in years past, and despite the call of the UN drug conventions for treatment, rehabilitation, and aftercare for drug abuse, the Board does not congratulate or note with approval the implementation of new methadone programs to address what in Asian countries has been a growing problem of injecting drug use and associated HIV infection.

Indeed, the Board continues to see such expansion of treatment primarily in terms of risks of diversion of legal medicines to illegal markets, calling on countries to strengthen control measures on methadone and buprenorphine. The Board notes with concern the lack of adequate access to opioids for pain management (paras 97, 208-213), yet makes no comment on the shortage or illegality of methadone or buprenorphine treatment for addiction in countries across the former Soviet Union and Asia.

In fact, the comment that supply of such treatment has risen slightly or decreased in many developing/transitional countries (para 276) - a development that should provoke alarm from the body responsible for helping countries to accurately estimate need for methadone or buprenorphine-is not accompanied by any expression of concern. In a report that contains multiple paragraphs on the danger of celebrity drug use, this omission is striking.

As in years past, the 2007 report does express strong opposition to medically supervised safer injection facilities, (paras 161, 369), saying that such programs are in contravention to international drug control treaties. The INCB’s recommendations include a call for countries with safer injection sites to close those facilities and instead provide appropriate "evidence-based" programs (Recommendation 24, at para 734). This demand is itself in tension with the evidence, since the benefits of safer injection facilities have in fact been documented in peer-reviewed literature and include fewer deaths from overdose, more referrals to treatment services, and a reduced risk of HIV and hepatitis transmission through decreased syringe sharing.

The INCB does not mention the 2002 analysis of the Legal Affairs section of the UN International Drug Control Programme, which detailed arguments justifying safer injection facilities, as well as other harm reduction programs, implying that such programs do not contravene drug conventions. The Board’s call for the cessation of efforts to provide "safer crack" kits (para 369) was similarly undocumented.

Finally, the Board does extend welcome attention to the question of drug treatment, rehabilitation and reintegration, noting that programs need clearly articulated objectives and evaluation, that treatment should be comprehensive and evidence-based, and that treatment should be available in prisons (paras 56, 505). This, and the Board’s call for suitable facilities and close cooperation between criminal justice and health agencies (para 56), are important, though the 2007 report remains silent on the many known instances in which criminal justice authorities decided to place large numbers of drug users in compulsory treatment that does not meet minimum medical standards.

In China, for example, where UNODC estimates that as many as 340,0000 are interned in compulsory detoxification and re-education through labour centres, the Board restricted itself to observing that treatment should be “comprehensive and evidence based,” (para 505) but makes no mention of the compulsory labour, lack of access to medication-assisted treatment, or human rights abuses reported in such facilities.

The Board visited Viet Nam in 2007 and notes the country’s efforts to strengthen HIV prevention and treatment. While expressing concern about relapse and offering a general reminder of the importance of evaluating different modalities for drug abuse treatment (para 539), the Board omits mention of what UNODC estimates to be more than 50,000 drug users interned for as long as five years in facilities that offer no HIV treatment and little drug treatment besides “moral re-education” and labour at low wages.

The Board’s note that treatment does not need to be voluntary to be effective (para 57) is similarly notable for its failure to address the ethical or human rights issues involved in compulsory treatment at the country level. The Board, for example, notes that the Russian Federation is considering legislation on compulsory treatment and the establishment of special medical centres (para 664) without noting that Russian authorities have banned the best studied and most effective forms of medication-assisted treatment.

Taken as a whole, the 2007 Annual Report shows some signs of a more balanced approach by the INCB to the real policy dilemmas that governments face in designing and implementing their drug control policies. While this is welcome, the method of operation of the Board, and its approach to these issues, still fall a long way short of what is necessary for it to play a positive and objective role in helping governments to find the right balance between their drug control obligations, and wider policy objectives related to social development, public health, and human rights protections.

Adapted from: The International Narcotics Control Board: Current Tensions and Options for Reform, IDPC Briefing Paper 7, February 2008

  • Labels
    HIV/AIDS | conventions | INCB | harm reduction

Drugs in the News

  • Are your illegal drugs pure? New Zealand will check them for you
    09.04.2021
  • Big tobacco is coming for legal marijuana
    08.04.2021
  • Mayor of London to examine benefits of cannabis legalisation
    05.04.2021
  • Schumer: Senate will act on marijuana legalization with or without Biden
    03.04.2021
  • New chairman of CLA wants ganja industry to earn maximum benefits globally
    02.04.2021
  • Pilot trials with cannabis
    01.04.2021
More news

Weblog

    A new EU Drug Strategy is being repared by the German presidencyA new EU Drug Strategy is being repared by the German presidency
    08.10.2020
More weblog

Hilites

Balancing Treaty Stability and Change

balancing hilite

Inter se modification of the UN drug control conventions to facilitate cannabis regulation


Connecting the dots...

connecting dots hilite

Human rights, illicit cultivation and alternative development


Morocco and Cannabis

morocco cannabis hilite

Reduction, containment or acceptance


The Rise and Decline of Cannabis Prohibition

rise decline hilite

The History of Cannabis in the UN Drug Control System and Options For Reform


Tags

10-year Review  20 1998 UNGASS  26 2005 CND debate  8 2016 UNGASS  126 2019 HLM  5 activism  22 afghanistan  24 show all

Tags

10-year Review  20 1998 UNGASS  26 2005 CND debate  8 2016 UNGASS  126 2019 HLM  5 activism  22 afghanistan  24 hide
africa  7 albania  11 alternative development  115 alternatives to policing  2 amnesty  69 appellation of origin  3 argentina  32 asean  9 ATS  15 australia  94 ayahuasca  6 bahamas  4 ballot 2012  155 banking  44 barbados  11 belgium  32 belize  10 bermuda  9 bolivia  115 brazil  93 brownfield doctrine  24 burma  42 california  202 cambodia  12 canada  498 cannabinoids  89 cannabis  2837 cannabis clubs  189 cannabis industry  370 caribbean  145 caricom  33 cbd oil  1 central america  5 chile  21 china  46 civil society  37 CND  126 coca  212 cocaine  61 coffee shop  211 cognitive decline  30 colombia  147 colorado  160 compulsary detention  19 conflict  3 conventions  250 corporate capture  37 corruption  3 costa rica  10 crack  51 craft cannabis  27 crime  68 czech republic  31 dark net  4 death penalty  2 decertification  1 decriminalization  837 deforestation  8 denmark  120 drug checking  36 drug consumption rooms  182 drug courts  22 drug markets  135 drug testing  7 drug trade  48 e-cigarettes  1 e-joint  2 ecstasy  59 ecuador  22 egypt  16 el salvador  2 environment  15 eradication  126 essential medicines  25 estonia  1 eswatini  4 european drug policy  67 expert advisory group  9 extrajudicial killings  92 fair trade  13 fentanyl  75 france  103 fumigation  25 gateway theory  29 georgia  2 germany  151 ghana  16 global commission  46 greece  18 guatemala  31 guatemala initiative  47 harm reduction  330 hemp  39 heroin  128 heroin assisted treatment  77 HIV/AIDS  61 home cultivation  84 honduras  3 human rights  247 illinois  10 incarceration  51 INCB  135 india  88 indonesia  34 informal drug policy dialogues  22 inter se modification  13 iran  14 ireland  15 israel  56 italy  34 jamaica  165 japan  3 kava  3 kazakhstan  5 ketamine  27 khat  36 kratom  27 kyrgyzstan  1 laos  2 latin american debate  115 law enforcement  385 lebanon  41 legal highs  63 legalization  1398 lesotho  6 luxembourg  33 malaysia  7 malta  18 medical cannabis  605 mental health  44 methamphetamine  41 mexico  204 Mid-Term Review  1 mild stimulants  37 money laundering  53 morocco  99 naloxone  13 nepal  6 netherlands  286 new york  25 new zealand  65 NIDA  5 nitrous oxide  6 norway  16 NPS  10 opinion polls  121 opioids  134 opium  90 oregon  29 overdose kits  4 pakistan  9 panama  5 paraguay  4 pardon  2 patents  18 peace  22 peru  42 peyote  3 philippines  86 pleasure  5 police pacification  18 portugal  66 potency  2 precursors  6 prevention  3 prison situation  96 producers  122 prohibition  141 proportionality  110 psychedelics  11 psychosis  53 puerto rico  3 racism  24 reclassification  116 recriminalisation  36 regulation  1204 russia  36 sacramental use  11 safe supply  21 safer crack  28 scheduling  24 scientific research  135 sdg  2 security  14 senegal  1 sentencing  66 singapore  6 social justice  60 south africa  64 spain  76 st lucia  9 st vincent and grenadines  29 substance-use disorder  18 substitution treatment  30 sweden  26 switzerland  134 synthetic cannabinoids  30 taxation  40 teen use  43 thailand  54 thresholds  40 tobacco industry  15 tramadol  17 treatment  22 trinidad & tobago  15 tunisia  13 UK  254 UN drug control  422 UNGASS  58 UNODC  107 uruguay  143 US drug policy  1128 vaping  2 venezuela  5 vietnam  5 violence  131 WHO  60 world drug report  11

This website

UN Drug Control

In 2011 the 1961 UN Single Convention on drugs will be in place for 50 years. In 2012 the international drug control system will exist 100 years since the International Opium Convention was signed in 1912 in The Hague. Does it still serve its purpose or is a reform of the UN Drug Conventions needed? This site provides critical background.

Drug Law Reform on the map

dlronthemap_und

Copyright © 2016 Drug Law Reform in Latin America

Website by WebWolf